Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

This registry study follows patients with end-stage kidney disease who receive a decellularized (processed) femoral artery graft called Nexeon AVX as a way to create a working access site for hemodialysis (a permanent vascular access to connect to a dialysis machine). The study tracks how well the graft works over time. **You may be eligible if...** - You are 18 or older - You have end-stage renal disease (kidney failure) and need hemodialysis - You need a vascular access graft and your doctor recommends this type of graft as a viable option - You are willing to comply with follow-up visits **You may NOT be eligible if...** - You are participating in another investigational study - You have a known allergy to any of the processing agents used to make the graft (certain antibiotics or chemicals) - You have had a heart attack in the past 6 months, severe heart disease, or unstable angina - You have severe peripheral vascular disease in your arms - You are unable or unwilling to attend follow-up visits Talk to your doctor to see if this trial is right for you.